Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1988 May;72(5):363–367. doi: 10.1136/bjo.72.5.363

Experimental studies on the pathogenesis of retinopathy of prematurity.

M Prost 1
PMCID: PMC1041455  PMID: 2456093

Abstract

The angiogenic activity of various parts of the retina in kittens with oxygen-induced retinopathy has been studied by the use of a corneal micropocket technique and chorioallantoic assay. The results indicate that in retinopathy of prematurity the most important role in the pathogenesis of fibrovascular proliferation is played by the so-called primary avascular retina, that is, that part of the retina which has not yet been vascularised during ontogenesis.

Full text

PDF
363

Images in this article

364Image
on p.364
365Image
on p.365

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASHTON N., WARD B., SERPELL G. Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia. Br J Ophthalmol. 1954 Jul;38(7):397–432. doi: 10.1136/bjo.38.7.397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ashton N. Oxygen and the growth and development of retinal vessels. In vivo and in vitro studies. The XX Francis I. Proctor Lecture. Am J Ophthalmol. 1966 Sep;62(3):412–435. doi: 10.1016/0002-9394(66)91322-5. [DOI] [PubMed] [Google Scholar]
  3. Ashton N. The pathogenesis of retrolental fibroplasia. Ophthalmology. 1979 Oct;86(10):1695–1699. doi: 10.1016/s0161-6420(79)35330-1. [DOI] [PubMed] [Google Scholar]
  4. COGAN D. G. DEVELOPMENT AND SENESCENCE OF THE HUMAN RETINAL VASCULATURE. Trans Ophthalmol Soc U K. 1963;83:465–489. [PubMed] [Google Scholar]
  5. Chen C. H., Chen S. C. Angiogenic activity of vitreous and retinal extract. Invest Ophthalmol Vis Sci. 1980 Jun;19(6):596–602. [PubMed] [Google Scholar]
  6. Ernest J. T., Goldstick T. K. Retinal oxygen tension and oxygen reactivity in retinopathy of prematurity in kittens. Invest Ophthalmol Vis Sci. 1984 Oct;25(10):1129–1134. [PubMed] [Google Scholar]
  7. Ezra D. B. Neovasculogenesis. Triggering factors and possible mechanisms. Surv Ophthalmol. 1979 Nov-Dec;24(3):167–176. doi: 10.1016/0039-6257(79)90020-1. [DOI] [PubMed] [Google Scholar]
  8. Federman J. L., Brown G. C., Felberg N. T., Felton S. M. Experimental ocular angiogenesis. Am J Ophthalmol. 1980 Feb;89(2):231–237. doi: 10.1016/0002-9394(80)90116-6. [DOI] [PubMed] [Google Scholar]
  9. Flynn J. T., O'Grady G. E., Herrera J., Kushner B. J., Cantolino S., Milam W. Retrolental fibroplasia: I. Clinical observations. Arch Ophthalmol. 1977 Feb;95(2):217–223. doi: 10.1001/archopht.1977.04450020019002. [DOI] [PubMed] [Google Scholar]
  10. Gimbrone M. A., Jr, Cotran R. S., Leapman S. B., Folkman J. Tumor growth and neovascularization: an experimental model using the rabbit cornea. J Natl Cancer Inst. 1974 Feb;52(2):413–427. doi: 10.1093/jnci/52.2.413. [DOI] [PubMed] [Google Scholar]
  11. Glaser B. M., D'Amore P. A., Michels R. G., Brunson S. K., Fenselau A. H., Rice T., Patz A. The demonstration of angiogenic activity from ocular tissues. Preliminary report. Ophthalmology. 1980 May;87(5):440–446. doi: 10.1016/s0161-6420(80)35224-x. [DOI] [PubMed] [Google Scholar]
  12. Kalina R. E., Karr D. J. Retrolental fibroplasia. Experience over two decades in one institution. Ophthalmology. 1982 Feb;89(2):91-5, 103. doi: 10.1016/s0161-6420(82)34829-0. [DOI] [PubMed] [Google Scholar]
  13. Kinsey V. E., Arnold H. J., Kalina R. E., Stern L., Stahlman M., Odell G., Driscoll J. M., Jr, Elliott J. H., Payne J., Patz A. PaO2 levels and retrolental fibroplasia: a report of the cooperative study. Pediatrics. 1977 Nov;60(5):655–668. [PubMed] [Google Scholar]
  14. Kissun R. D., Hill C. R., Garner A., Phillips P., Kumar S., Weiss J. B. A low-molecular-weight angiogenic factor in cat retina. Br J Ophthalmol. 1982 Mar;66(3):165–169. doi: 10.1136/bjo.66.3.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lutty G. A., Thompson D. C., Gallup J. Y., Mello R. J., Patz A., Fenselau A. Vitreous: an inhibitor of retinal extract-induced neovascularization. Invest Ophthalmol Vis Sci. 1983 Jan;24(1):52–56. [PubMed] [Google Scholar]
  16. Nissenkorn I., Kremer I., Ben Sira I., Cohen S., Garner A. A clinicopathological case of retinopathy of prematurity (ROP) treated by peripheral cryopexy. Br J Ophthalmol. 1984 Jan;68(1):36–41. doi: 10.1136/bjo.68.1.36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Patz A. Clinical and experimental studies on retinal neovascularization. XXXIX Edward Jackson Memorial Lecture. Am J Ophthalmol. 1982 Dec;94(6):715–743. doi: 10.1016/0002-9394(82)90297-5. [DOI] [PubMed] [Google Scholar]
  18. Patz A. Studies on retinal neovascularization. Friedenwald Lecture. Invest Ophthalmol Vis Sci. 1980 Oct;19(10):1133–1138. [PubMed] [Google Scholar]
  19. Patz A. The role of oxygen in retrolental fibroplasia. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1975;195(2):77–85. doi: 10.1007/BF00417111. [DOI] [PubMed] [Google Scholar]
  20. Payne J. W., Patz A. Fluorescein angiography in retrolental fibroplasia. Int Ophthalmol Clin. 1977 Summer;17(2):121–135. doi: 10.1097/00004397-197701720-00011. [DOI] [PubMed] [Google Scholar]
  21. Taylor C. M., Weiss J. B., Kissun R. D., Garner A. Effect of oxygen tension on the quantities of procollagenase-activating angiogenic factor present in the developing kitten retina. Br J Ophthalmol. 1986 Mar;70(3):162–165. doi: 10.1136/bjo.70.3.162. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES